VRiT is developing a handheld bioprinting system that allows surgeons to apply personalized bioinks and therapeutics directly onto wounds, eliminating the need for autografts. Our device, INSITE, enables precise, in-situ deposition of high-fidelity biomaterials to support rapid, functional skin regeneration at the point of care. In parallel, we are advancing SHIELD, our next-generation cellular therapy. Together, INSITE and SHIELD form an integrated wound-repair platform that enables uniform coverage without donor sites, while reducing pain, scarring, and hospitalization costs.